Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Kwan

Showing results (91-100 of 413) with videos related to

Pageof 42
Sort By:
BMJ Neurology Open|December 22, 2025
Prognosis of people with focal epilepsy treated with anti-seizure medications (ASMs): a narrative review of current evidence and future directionsSarah Barnard, Emma Foster, Patrick Kwan, et al.
Epilepsy & Behavior : E&B|March 23, 2011
Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?Michael R Johnson, Nigel C K Tan, Patrick Kwan, et al.
Epilepsy & Behavior : E&B|November 29, 2021
Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizures: Authors' responseCharles B Malpas, Benjamin Johnstone, Dennis Velakoulis, et al.
Epilepsy & Behavior : E&B|August 26, 2022
Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: A longitudinal cohort studyJohn-Paul Nicolo, Zhibin Chen, Russell Nightscales, et al.
Epilepsy & Behavior : E&B|January 17, 2016
Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness SurveyShaloo Gupta, Patrick Kwan, Edward Faught, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 28, 2019
The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A <i>in vitro</i>Ziyan Fei, Mengyun Hu, Larry Baum, et al.
Pharmacogenomics|August 1, 2015
Point-of-care molecular diagnostic devices: an overviewChi Lan Nguyen Vu, Jianxiong Chan, Marian Todaro, et al.
BMJ Open|January 25, 2024
Role of machine learning in the management of epilepsy: a systematic review protocolRichard Shek-Kwan Chang, Shani Nguyen, Zhibin Chen, et al.
Epilepsy & Behavior : E&B|March 10, 2021
Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizuresBenjamin Johnstone, Charles B Malpas, Dennis Velakoulis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 6, 2019
First seizure presentations in adults: beyond assessment and treatmentEmma Foster, Patrick Carney, Danny Liew, et al.
Pageof 42

Showing results (91-100 of 413) with videos related to

Sort By:
Pageof 42
BMJ Neurology Open|December 22, 2025
Prognosis of people with focal epilepsy treated with anti-seizure medications (ASMs): a narrative review of current evidence and future directionsSarah Barnard, Emma Foster, Patrick Kwan, et al.
Epilepsy & Behavior : E&B|March 23, 2011
Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?Michael R Johnson, Nigel C K Tan, Patrick Kwan, et al.
Epilepsy & Behavior : E&B|November 29, 2021
Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizures: Authors' responseCharles B Malpas, Benjamin Johnstone, Dennis Velakoulis, et al.
Epilepsy & Behavior : E&B|August 26, 2022
Identification of factors associated with new-onset vascular disease in patients admitted for video-EEG monitoring: A longitudinal cohort studyJohn-Paul Nicolo, Zhibin Chen, Russell Nightscales, et al.
Epilepsy & Behavior : E&B|January 17, 2016
Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness SurveyShaloo Gupta, Patrick Kwan, Edward Faught, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 28, 2019
The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A <i>in vitro</i>Ziyan Fei, Mengyun Hu, Larry Baum, et al.
Pharmacogenomics|August 1, 2015
Point-of-care molecular diagnostic devices: an overviewChi Lan Nguyen Vu, Jianxiong Chan, Marian Todaro, et al.
BMJ Open|January 25, 2024
Role of machine learning in the management of epilepsy: a systematic review protocolRichard Shek-Kwan Chang, Shani Nguyen, Zhibin Chen, et al.
Epilepsy & Behavior : E&B|March 10, 2021
Psychiatric symptoms are the strongest predictors of quality of life in patients with drug-resistant epilepsy or psychogenic nonepileptic seizuresBenjamin Johnstone, Charles B Malpas, Dennis Velakoulis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 6, 2019
First seizure presentations in adults: beyond assessment and treatmentEmma Foster, Patrick Carney, Danny Liew, et al.
Pageof 42